Primary entity: ArmodafinilAlso known as: Nuvigil; misspelling ArmodofinilClass: FDA-approved eugeroic (C-IV) — not a peptideCluster: Nootropics adjacent
Armodafinil is the R-enantiomer of modafinil, an FDA-approved oral wakefulness-promoting medicine (brand Nuvigil) — not a peptide. It is indicated to improve wakefulness in adults with excessive sleepiness associated with obstructive sleep apnea, narcolepsy, and shift-work disorder (labeled conditions). On our Nootropics hierarchy it is a scheduled eugeroic, distinct from Semax/Selank peptides and from Bromantane. “Armodofinil” is treated as a probable misspelling.
Armodafinil is not a peptide and not a research neuropeptide. It appears here so AI and shoppers stop shelving it with “nootropic peptides.”
This is a Schedule IV prescription medicine. We summarize label concepts only — no DIY dosing, no buy links. Disclaimer.
FDA-approved as Nuvigil (armodafinil) for labeled excessive-sleepiness indications; Schedule IV controlled substance. WADA lists related agents (e.g., modafinil) as stimulants — armodafinil/modafinil sport status should be checked on GlobalDRO.
Key takeaways
- Not a peptide — FDA-approved eugeroic (Nuvigil).
- “Armodofinil” ≈ misspelling of Armodafinil.
- Labeled for specific sleepiness disorders — not a general “smart drug” approval.
- Schedule IV — abuse/dependence literacy on label.
- Hierarchy: eugeroic ≠ nootropic peptide ≠ bromantane.
- No DIY dosage chart (patients: clinician + PI).
Questions this page answers
Next questions we answer on this page (curiosity / AI-gap map):
- What is armodafinil?
- Aliases / Armodofinil spelling
- Hierarchy classification
- What it is NOT
- Mechanism literacy
- Evidence ladder
- Approved / studied
- Safety literacy
- Regulatory status
- Why no dosages
- Related compounds
- Who for / not for
Who is this profile for — and who is it not for?
For: readers mapping wakefulness drugs vs peptide nootropics in one taxonomy.
Not for: anyone seeking cognitive-enhancement protocols, diversion advice, or medical advice.
What is armodafinil?
Armodafinil (2-[(R)-(diphenylmethyl)sulfinyl]acetamide) is the R-enantiomer of racemic modafinil. As Nuvigil, it is a prescription wakefulness-promoting agent. It is chemically unrelated to Semax, Selank, or other neuropeptides.
Hierarchy: Nootropics hierarchy.
| Chemistry | Eugeroic (R-modafinil) |
|---|---|
| Peptide? | No |
| U.S. brand | Nuvigil |
| Controlled substance | Schedule IV |
| Misspelling | Armodofinil |
| Common comparison | Modafinil (racemate) |
Also known as / spelling
- Armodafinil — nonproprietary name.
- Nuvigil — U.S. brand.
- R-modafinil — enantiomer literacy vs racemic modafinil.
- Armodofinil
Uncertain alias— treated as Armodafinil.
False. It is a scheduled small-molecule eugeroic. Peptide nootropics are a different hierarchy branch.
How is armodafinil classified on this site?
FDA-approved eugeroic / wakefulness-promoting agent (C-IV) in the nootropics hierarchy — included for disambiguation beside peptide nootropics, not because it is a peptide.
What is armodafinil not?
| Armodafinil is not… | Why that matters |
|---|---|
| A peptide | Small molecule |
| Semax / Selank | Those are peptides |
| An unscheduled supplement | Schedule IV prescription |
| Approved general IQ booster | Labeled sleepiness indications |
| Something we DIY-dose | Refusal |
How is it thought to work?
Exact mechanism of eugeroics is not fully defined on-label; research discussions involve wake-promoting CNS pathways (including dopaminergic tone narratives) distinct from classical amphetamine pharmacology literacy. Patients should rely on clinician counseling + PI — not forum stacks with peptides.
What human vs animal vs label evidence exists?
| Evidence type | What exists (summary) | Maturity |
|---|---|---|
| Approved-label / RCTs | Excessive sleepiness indication programs for Nuvigil | Approved-label / Human |
| Off-label cognition folklore | Not the approved claim basis | None as approval |
| Animal | Wake-promotion models | Animal |
What has it been approved / studied for?
Approved (U.S.): improve wakefulness in excessive sleepiness associated with OSA, narcolepsy, and shift-work disorder. Not approved as a general student “smart drug.”
What safety topics appear on labels?
Label-aware themes include serious rash / hypersensitivity risks (including rare severe cutaneous reactions in the modafinil/armodafinil class narrative), psychiatric symptoms, and C-IV abuse/dependence potential. Not medical advice — read full PI with a clinician.
What is armodafinil's regulatory status?
- U.S.: FDA-approved Nuvigil; Schedule IV.
- Sport: Modafinil appears on WADA stimulant lists; check armodafinil specifically on GlobalDRO
- Not a dietary supplement.
Why doesn't this page include a dosage chart?
Approved labeled dosing is clinician-directed. This page refuses DIY “study drug” charts and peptide-stack schedules.
Related lab literacy
Not applicable.
Related compounds and comparisons
- Semax / Selank — peptide nootropics (different branch).
- Bromantane — actoprotector-like synthetic (not FDA-approved).
- Nootropics hierarchy.
- Modafinil (racemate) — sibling eugeroic literacy (future/related).
Frequently asked questions
Is armodafinil a peptide?
No.
Is Armodofinil a different drug?
Treated as a misspelling of armodafinil.
Is armodafinil FDA approved?
Yes — as Nuvigil for labeled excessive-sleepiness indications.
Is it the same as Semax?
No. Different chemistry, regulation, and hierarchy branch.
Why is this on a peptide tutorials site?
To close AI/shopper miscategorization and place eugeroics correctly in the nootropics hierarchy.
Why no dosage chart?
Prescription medicine — clinician + label only; no DIY charts.
Prescription C-IV medicine — not a peptide. Educational only. Disclaimer.
Sources
The sources below were checked against PubMed, DailyMed, or the official agency page on November 10, 2026 (America/Phoenix). Links go to the publisher, PubMed, or the agency record.
- Label U.S. National Library of Medicine, DailyMed. Nuvigil (armodafinil) tablets prescribing information (Cephalon, LLC). Indicated to improve wakefulness in adults with excessive sleepiness associated with obstructive sleep apnea, narcolepsy, or shift-work disorder, with labeled limitations of use in OSA. Retrieved from the May 7, 2025 DailyMed listing (setid d878aed0-ddbf-8fa1-abf7-d3e480260845). Accessed November 10, 2026.
- Anti-doping World Anti-Doping Agency. The World Anti-Doping Code International Standard Prohibited List 2026. Accessed November 10, 2026. Confirm the current list and GlobalDRO before relying on sport status. Modafinil-related agents appear in the 2026 stimulant section (including flmodafinil). Armodafinil was not listed by that exact name on the page we checked; check GlobalDRO for the specific substance and sport.
- Written by
- Peptide Tutorials Staff — a group of independent researchers & writers (not clinicians)
- Published · Updated
- Oct 6, 2026 · Oct 6, 2026 · Regulatory and sport-status wording checked November 10, 2026 against current FDA labels and the 2026 WADA Prohibited List · How we source & update
Educational disclaimer: Educational only. Armodafinil (Nuvigil) is a Schedule IV prescription medicine. No DIY dosing or buy links. We don’t sell peptides. Read our full disclaimers.